Top Markets
Coin of the day
Zhejiang AngLiKang Pharmaceutical CO.,LTD. Zhejiang AngLiKang Pharmaceutical CO.,LTD.

Zhejiang AngLiKang Pharmaceutical CO.,LTD.

002940
Classificação em ações #11260
Zhejiang AngLiKang Pharmaceutical CO.,LTD. is a company primarily focused on... Zhejiang AngLiKang Pharmaceutical CO.,LTD. is a company primarily focused on the manufacturing and distribution of various pharmaceutical goods. Their operations span the production and sale of active pharmaceutical ingredients (APIs), finished drug formulations, and empty capsules for medical use. The company's existing product line encompasses treatments for a variety of conditions, including anti-infective agents, antihypertensives for blood pressure management, medications for digestive system health, and respiratory preparations. Beyond its current offerings, AngLiKang is also deeply involved in drug research and development. Their R&D efforts are concentrated on creating new therapies, with a particular emphasis on oral cephalosporin antibiotics, as well as treatments for cardiovascular, renal (kidney), and central nervous system diseases. The company was established in 2001 and maintains its headquarters in Shengzhou, China.
Preço da ação
$3.69
Última sincronização: 2026-08-28
Valor de mercado
$722.97M
Variação (1 dia)
-1.62%
Variação (1 ano)
-46.81%
País
CN
Negociar Zhejiang AngLiKang Pharmaceutical CO.,LTD. (002940)

Categoria

Lucros da Zhejiang AngLiKang Pharmaceutical CO.,LTD. (002940)
Lucros em 2026 TTM: 0
De acordo com os últimos relatórios financeiros da Zhejiang AngLiKang Pharmaceutical CO.,LTD., os ganhos atuais da empresa são de 0. Em 2026, a empresa teve ganhos de 0, igual a aos ganhos de 2026, que foram de 0. Os ganhos apresentados nesta página são os ganhos antes de juros e impostos, conhecidos como EBIT.
Histórico de lucros da Zhejiang AngLiKang Pharmaceutical CO.,LTD. de 2026 a 2026
Lucros no final de cada ano
Ano Lucros Alterar
Não há dados suficientes para as datas fornecidas.
Lucros de empresas semelhantes ou concorrentes